Gene · 26826
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature. | Int J Mol Sci | 2023 | 36982210 | PubTator, text mining | PubMed |
| Two oncomiRs, miR-182-5p and miR-103a-3p, Involved in Intravenous Leiomyomatosis. | Genes (Basel) | 2023 | 36980984 | PubTator, text mining | PubMed |
| Droplet Digital PCR Quantification of Selected Intracellular and Extracellular microRNAs Reveals Changes in Their Expression Pattern during Porcine In Vitro Adipogenesis. | Genes (Basel) | 2023 | 36980955 | PubTator, text mining | PubMed |
| MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma. | Diagnostics (Basel) | 2023 | 36980512 | PubTator, text mining | PubMed |
| Serum miR-181d-5p levels in response to controlled ovarian stimulation: predictive value and biological function. | JBRA Assist Reprod | 2023 | 36952624 | PubTator, text mining | PubMed |
| Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity. | Noncoding RNA Res | 2023 | 36949748 | PubTator, text mining | PubMed |
| Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients' survival and response to neoadjuvant chemotherapy. | Virchows Arch | 2023 | 36939902 | PubTator, text mining | PubMed |
| Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approach. | Oncol Rep | 2023 | 36929268 | PubTator, text mining | PubMed |
| The severity of COVID-19 in hypertensive patients is associated with mirSNPs in the 3' UTR of ACE2 that associate with miR-3658: In silico and in vitro studies. | J Taibah Univ Med Sci | 2023 | 36926053 | PubTator, text mining | PubMed |
| Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease. | Ann Transl Med | 2023 | 36923095 | PubTator, text mining | PubMed |
| MicroRNA Profiling of Self-Renewing Human Neural Stem Cells Reveals Novel Sets of Differentially Expressed microRNAs During Neural Differentiation In Vitro. | Stem Cell Rev Rep | 2023 | 36918496 | PubTator, text mining | PubMed |
| MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. | Transl Oncol | 2023 | 36907052 | PubTator, text mining | PubMed |
| Identification of MGMT Downregulation Induced by miRNA in Glioblastoma and Possible Effect on Temozolomide Sensitivity. | J Clin Med | 2023 | 36902848 | PubTator, text mining | PubMed |
| Prognostic value of microRNA-125a expression status in molecular groups of pediatric medulloblastoma. | Childs Nerv Syst | 2023 | 36892621 | PubTator, text mining | PubMed |
| miRNA-1246, HOTAIR, and IL-39 signature as potential diagnostic biomarkers in breast cancer. | Noncoding RNA Res | 2023 | 36865390 | PubTator, text mining | PubMed |
| Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha. | Mol Ther Nucleic Acids | 2023 | 36845338 | PubTator, text mining | PubMed |
| Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer. | J Oncol | 2023 | 36844871 | PubTator, text mining | PubMed |
| A Group of Tumor-Suppressive micro-RNAs Changes Expression Coordinately in Colon Cancer. | Curr Issues Mol Biol | 2023 | 36826008 | PubTator, text mining | PubMed |
| Differential Expression Profile of Salivary oncomiRNAs among Smokeless Tobacco Users. | Eur J Dent | 2023 | 36812928 | PubTator, text mining | PubMed |
| MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms. | Mol Oncol | 2023 | 36795001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26826/papers?page=6